Physician Quick Search
By Name:
By Specialty:
Internal Medicine / Pulmonary and Critical Care Medicine
The Washington University physicians in the Department of Internal Medicine encompass 14 specialty clinical divisions.

Over 270 physicians in the department of medicine treat patients with a wide range of diseases, disorders and conditions.
Your Healthy Update

Like us on Facebook
Text Size: S M L
Search

Share

Internal Medicine / Pulmonary and Critical Care Medicine

Marin H. Kollef, MD, FACP, FCCP

Current Position
Professor, Medicine
Division of Pulmonary and Critical Care Medicine
Director, Medical Intensive Care Unit, Barnes-Jewish Hospital
Director, Respiratory Care Services, Barnes-Jewish Hospital


Specialty Areas
Pulmonary Disease
Critical Care Medicine

Patients Seen At
Barnes-Jewish Hospital
Medical Intensive Care Unit
One Barnes-Jewish Hospital Plaza
St. Louis, MO  63110
View Campus Map   View Driving Directions

Mailing Address
Washington University School of Medicine
Division of Pulmonary and Critical Care Medicine
660 South Euclid Avenue, Campus Box 8052
St. Louis, MO  63110

Areas of Clinical Interest
Critical care medicine, pneumonia, emphysema,

Board Certification
Pulmonary Disease -- Certified
Internal Medicine -- Certified
Critical Care Medicine -- Certified

This physician provides professional consultation only.

Medical Education
Medical Degree: University Of Rochester, Rochester, New York, 1983
Residency: Internal Medicine, Madigan Army Medical Center, Tacoma, Washington, 1986
Fellowship: Pulmonary Disease and Critical Care, Madigan Army Medical Center, Tacoma, Washington, 1988
Fellowship: Fred Hutchinson Cancer Institute, Seattle, Washington; Bone Marrow Transplant Critical Care Service, 1988
Hospital Affiliations
Barnes-Jewish Hospital

Honors and Awards
Listed in Best Doctors in America, 2002-2013 (Best Doctors, Inc.)
Listed in America's Top Doctors, 2002-2012 (Castle Connolly Medical Ltd.)

Disclosure of Financial Interests with Industry
Washington University and its physicians are committed to ensuring integrity and objectivity in medical decision-making. Some of our physicians work collaboratively with pharmaceutical or medical device companies to develop innovative ideas and products that can improve health care delivery and clinical outcomes for patients. In some instances, our faculty physicians are paid by these commercial companies to provide advice on product design or to speak about the use of medications, devices, equipment or procedures. These payments may include: a) compensation for consulting and speaking engagements, b) equity, and/or c) royalties for products invented by our faculty. Any payments to Washington University physicians must be based on tangible services and may not exceed fair market value for their work. In addition to disclosure on this web site, physicians earning more than $10,000 per year must disclose their corporate financial relationship in writing to patients when prescribing or using that company's products.

Dr. Marin H. Kollef reported the following earned financial interests during calendar year 2011. Move your mouse over a header for more info.
Company
Royalties
Royalties: When a faculty member invents or conceives a new or improved process or product, the company that manufactures the product will make royalty payments to the faculty member. Royalty payments usually are a small percentage of the company’s revenue related to that product.
Consulting &
Advisory Boards
Consulting and Advisory Boards: Faculty may be paid to provide expertise to a company by being their consultant, or by serving on an advisory board.
Speaker Fees
Speaker Fees: Companies may pay faculty to speak to professional audiences about their products.
Merck   $25,001-$50,000 
Cubist  $10,001-$25,000 $50,001-$100,000 
Hospira   $25,001-$50,000 
To learn more about Washington University's policies on collaborations with industry, click here.

Selected or Recent Journal Articles
Labelle A, Juang P, Reichley R, Micek S, Hoffmann J, Hoban A, Hampton N, Kollef M. The determinants of hospital mortality among patients with septic shock receiving appropriate initial antibiotic treatment*. Crit Care Med. 2012 Jul.

Kollef M, Micek S, Hampton N, Doherty JA, Kumar A. Septic shock attributed to Candida infection: importance of empiric therapy and source control. Clin Infect Dis. 2012 Jun.

Kollef MH, Hamilton CW, Ernst FR. Economic impact of ventilator-associated pneumonia in a large matched cohort. Infect Control Hosp Epidemiol. 2012 Mar.

Shorr AF, Zilberberg MD, Reichley R, Kan J, Hoban A, Hoffman J, Micek ST, Kollef MH. Validation of a clinical score for assessing the risk of resistant pathogens in patients with pneumonia presenting to the emergency department. Clin Infect Dis. 2012 Jan 15.

Micek ST, Reichley RM, Kollef MH. Health care-associated pneumonia (HCAP): empiric antibiotics targeting methicillin-resistant Staphylococcus aureus (MRSA) and Pseudomonas aeruginosa predict optimal outcome. Medicine (Baltimore). 2011 Nov.

Kollef MH. Prevention of ventilator-associated pneumonia or ventilator-associated complications: a worthy, yet challenging, goal. Crit Care Med. 2012 Jan.

Kollef MH, Golan Y, Micek ST, Shorr AF, Restrepo MI. Appraising contemporary strategies to combat multidrug resistant gram-negative bacterial infections--proceedings and data from the Gram-Negative Resistance Summit. Clin Infect Dis. 2011 Sep.

Labelle A, Kollef MH. Healthcare-associated pneumonia: approach to management. Clin Chest Med. 2011 Sep.

Dickinson JD, Kollef MH. Early and adequate antibiotic therapy in the treatment of severe sepsis and septic shock. Curr Infect Dis Rep. 2011 Oct.

Demertzis LM, Kollef MH. The resuscitation package in sepsis. Curr Infect Dis Rep. 2010 Sep.

Dallas J, Brown SM, Hock K, Scott MG, Skrupky LP, Boyle WA 3rd, Kollef MH. Diagnostic utility of plasma procalcitonin for nosocomial pneumonia in the intensive care unit setting. Respir Care. 2011 Apr.

Kollef MH, Zilberberg MD, Shorr AF, Vo L, Schein J, Micek ST, Kim M. Epidemiology, microbiology and outcomes of healthcare-associated and community-acquired bacteremia: a multicenter cohort study. J Infect. 2011 Feb.

Sawyer AM, Deal EN, Labelle AJ, Witt C, Thiel SW, Heard K, Reichley RM, Micek ST, Kollef MH. Implementation of a real-time computerized sepsis alert in nonintensive care unit patients. Crit Care Med. 2011 Mar.

Theodoro D, Krauss M, Kollef M, Evanoff B. Risk factors for acute adverse events during ultrasound-guided central venous cannulation in the emergency department. Acad Emerg Med. 2010 Oct.

Kollef MH. Prevention of nosocomial pneumonia in the intensive care unit: beyond the use of bundles. Surg Infect (Larchmt). 2011 Jun.

For more articles and abstracts, take this off-site link to the National Library of Medicine Pub Med page for Dr. Marin Kollef

Washington University Physicians are the medical staff of  Barnes-Jewish Hospital and Children's Hospital - St. Louis Employment   About Us   Top Stories   For Your Protection      Site Map
Copyright 2013 Washington University School of Medicine
Copyright 2013 Washington University School of Medicine